Subsequent chemotherapy improves survival outcome in advanced non-small-cell lung cancer with acquired tyrosine kinase inhibitor resistance.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works matching IS 15257304 AND DT 2010 AND VI 11 AND IP 1
Results: 15
1
2
Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non-Small-Cell Lung Cancer: Results of a Phase I Study.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Plasma nucleosome levels might predict response to therapy in patients with advanced non-small-cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Oxaliplatin in First-line Therapy for Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
5
CLINICAL Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 2
- By:
- Publication type:
- Article
6
Selected Clinical Trials in First-line Metastatic Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 61, doi. 10.1016/S1525-7304(11)70040-7
- By:
- Publication type:
- Article
7
Lung Carcinogenicity of Sulfur Mustard.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 13, doi. 10.3816/CLC.2010.n.002
- By:
- Publication type:
- Article
8
Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 30, doi. 10.3816/CLC.2010.n.005
- By:
- Publication type:
- Article
9
Response to Pemetrexed Chemotherapy in Lung Adenocarcinoma-Bronchioloalveolar Carcinoma Insensitive to Erlotinib.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 57, doi. 10.3816/CLC.2010.n.009
- By:
- Publication type:
- Article
10
Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer: Results of a Phase I Study.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 45, doi. 10.3816/CLC.2010.n.007
- By:
- Publication type:
- Article
11
Initial Experience With Endobronchial Ultrasound in an Academic Thoracic Surgery Program.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 25, doi. 10.3816/CLC.2010.n.004
- By:
- Publication type:
- Article
12
Plasma Nucleosome Levels Might Predict Response to Therapy in Patients With Advanced Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 36, doi. 10.3816/CLC.2010.n.006
- By:
- Publication type:
- Article
13
Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 18, doi. 10.3816/CLC.2010.n.003
- By:
- Publication type:
- Article
14
Subsequent Chemotherapy Improves Survival Outcome in Advanced Non–Small-Cell Lung Cancer With Acquired Tyrosine Kinase Inhibitor Resistance.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 51, doi. 10.3816/CLC.2010.n.008
- By:
- Publication type:
- Article
15
A Review of Epidermal Growth Factor Receptor/HER2 Inhibitors in the Treatment of Patients With Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 1, p. 8, doi. 10.3816/CLC.2010.n.001
- By:
- Publication type:
- Article